Evaluation of Fiasp ® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
Condition: Diabetes Mellitus, Type 1 Interventions: Drug: Fiasp; Drug: Novolog Sponsors: Stanford University; Medtronic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2018 Category: Research Source Type: clinical trials
